BioSpace News Archive

BioForward, Wisconsin’s state association representing over 200 biohealth member companies, announced three additions to this year’s Board of Directors.

Anesthesia Business Consultants (ABC), a leading provider in billing and practice management for the anesthesia and pain management specialty, is pleased to announce it will be attending PRACTICE MANAGEMENT™ 2019 hosted by the American Society of Anesthesiologists (ASA).

EOS imaging (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), the pioneer of 2D/3D imaging and data solutions for orthopedics, previously announced in a press release dated December 11th, 2018, the success of the settlement-delivery of the share capital increase for an amount of €15,061,856.13 entirely subscribed by Fosun Pharmaceutical AG, an indirect subsidiary of Shanghai Fosun Pharmaceutical

The U.S. Food and Drug Administration approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures, as an adjunctive therapy (given with another primary treatment) in patients 10 years and older who have responded inadequately to several alternative (refractory) treatments.

AIDS Healthcare Foundation (AHF) today commended California Governor Gavin Newsom for his swift, out of the gate action to rein in runaway drug pricing in the nation’s most populous state, an action which also sets an example for similar gubernatorial action nationwide.

National Partners in Healthcare (NPH), a national healthcare organization delivering best in class anesthesiology services, announced today that Anesthesia Resources (AR) has joined NPH.

The REAM Foundation, in collaboration with the Milken Institute’s Center for Strategic Philanthropy, today announced the launch of the first dedicated misophonia grant program to encourage scientific progress, better understand the condition, and develop new treatments.

Bedfont, who has specialised in the design and manufacture of breath analysis medical devices for over 40 years, announces today that Dr Jafar Jafari will be the first appointment to its Gastrolyzer Medical Advisory Board.

The international scientific community is called to submit applications for the premiere of the world’s first award for cutting edge contributions to the progress of life sciences through lipidomics, the 2019 “Lipidomics Excellence Award” (LEA) until 30 March, 2019. Prof. Dr. Kai Simons, Professor and Director Emeritus at Max-Planck-Institute for Molecular Cell Biology and Genetics Dresden and Founder and CEO of Lipotype,

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for a Phase 1B clinical trial investigating the Company’s ROOT OF CANCER technology in patients with metastatic melanoma.